{
    "title": "GlaxoSmithKline suffers blow after US judge rules against it in lawsuit relating to its heartburn drug Zantac",
    "url": "https://www.dailymail.co.uk/money/markets/article-11899927/Glaxo-loses-bid-experts-Zantac-court-showdown.html",
    "date": "2023-03-24",
    "keywords": [
        "share",
        "judge",
        "cancer",
        "drug",
        "court",
        "zantac",
        "account",
        "risk",
        "fund",
        "glaxosmithkline",
        "lawsuit",
        "wrangle",
        "price",
        "compensation",
        "ruling",
        "gsk",
        "money",
        "diy",
        "investment",
        "fee",
        "blow",
        "ftse",
        "group",
        "pfizer",
        "sanofi",
        "centre",
        "storm",
        "medicine",
        "stock",
        "cent",
        "yesterday",
        "evelio",
        "grillo",
        "end",
        "hq",
        "vote",
        "confidence",
        "shot",
        "arm",
        "article",
        "spokesman",
        "consensus",
        "evidence",
        "ranitidine",
        "plaintiff",
        "case",
        "trialgrillos",
        "decision",
        "conflict",
        "robin",
        "rosenberg",
        "december",
        "science",
        "testing",
        "capital",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}